mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.5 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |